Search results
FDA advisers weigh benefits of weekly insulin for people with diabetes
CNN.com· 2 days agoMost types of insulin therapy, an important part of diabetes treatment for many people, are given as...
Pharma company moves headquarters from Midwest to Miami Beach - South Florida Business Journal
The Business Journals· 2 days agoSAB Biotherapeutics moved its corporate headquarters to Miami Beach ahead of a receiving clearance...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 5 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the US, regardless of ...
Amid ‘Ozempic babies’ questions, women account for more than 75% of young adults taking GLP-1 drugs,...
Market Watch· 5 days agoThe total number of adolescents and young adults prescribed GLP-1 drugs, which are used to treat...
GLP-1 Agonist Scripts Jumped 600% for Teens, Young Adults Since 2020
MedPage Today· 5 days agoThe number of adolescents and young adults prescribed a glucagon-like peptide-1 (GLP-1) receptor...
Column: Expand preventative services to reduce diabetes cases
The Virginian-Pilot· 5 days agoIt is no secret that Type 2 diabetes (T2D) is one of the most common chronic diseases in the United...
Losing Muscle with GLP-1 RAs? There May be a Drug for That
Medscape· 3 days agoMedications in development would preserve muscle mass and augment fat loss when used in combination...
Use of GLP-1 weight-loss drugs soars among teens, young adults
UPI· 5 days agoGLP-1 prescriptions among people ages 12 to 25 jumped by more than 594% (equivalent to a nearly...
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans | FOX 28 Spokane
FOX 28 Spokane· 5 days agoKey Takeaways The use of GLP-1 diabetes and weight-loss medications is soaring among teens and young adultsPrescription rates rose nearly 7-fold between ...
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential...
Fortune via Yahoo Finance· 1 day agoBarzilai cautions that GLP-1 receptor agonists are not a cure-all. “I'm not here calling for doctors...